Global Cell Engineering Service Market Growth (Status and Outlook) 2026-2032

October 2026 | 124 pages | ID: GDB604EAFF9EEN
LP Information

Abstracts

The global Cell Engineering Service market size is predicted to grow from US$ 4818 million in 2025 to US$ 8680 million in 2032; it is expected to grow at a CAGR of 8.8% from 2026 to 2032.

Cell engineering service refers to specialized research, development, and technical services that use cell culture, genetic modification, gene editing, transfection, clone screening, functional validation, cell banking, process optimization, and scale-up technologies to construct or modify cells with defined biological characteristics for research, drug development, biomanufacturing, and therapeutic applications. Service targets can include commonly used mammalian cell lines, primary cells, stem cells, immune cells, production cell lines, and other engineered cellular systems. Core service capabilities typically cover cell-line construction, gene knockout or knock-in, stable expression, point mutation, functional modification, single-clone screening, characterization, cell-bank establishment, and process development. Key evaluation dimensions include service-process coverage, cell types supported, engineering complexity, clone-screening capacity, automation level, project throughput, delivery cycle, quality-management capability, and scalability. This study focuses on Cell Engineering Service used in biopharmaceutical development, drug discovery, cell and gene therapy, regenerative medicine, diagnostics, contract research and development, academic research, and other biotechnology applications.

Key Findings

Cell Engineering Service is evolving from individual laboratory operations toward integrated development and validation workflows

Gene editing stable cell line development and functional validation remain core service capabilities

Demand is shifting toward more complex cell models higher automation and stronger reproducibility

Biopharmaceutical research cell therapy and drug discovery represent major downstream application environments

Market Trends

Cell Engineering Service is developing toward higher engineering complexity, greater automation, standardized workflows, and closer integration with downstream drug development and biomanufacturing processes. Traditional projects often focused on relatively independent operations such as transfection, stable cell-line construction, or clone screening, while current service models increasingly combine cell design, genetic modification, clone isolation, molecular characterization, functional validation, banking, and process development within coordinated workflows. Gene-editing technologies are broadening the range of achievable cellular modifications, while automated liquid handling, high-content imaging, single-cell analysis, and data-management tools are improving throughput and consistency. Demand is also expanding from conventional immortalized cell lines toward primary cells, stem cells, immune cells, disease-relevant models, and production cell lines. The long-term direction is toward platform-based services capable of supporting more complex engineering tasks, traceable data management, standardized quality control, and smoother transition from early research to translational and manufacturing stages.

Market Dynamics

Drivers

The expansion of biopharmaceutical research, targeted drug development, cell and gene therapy, regenerative medicine, and advanced biological research is increasing demand for customized engineered cells and standardized cellular models. Drug developers increasingly require cell systems that can reproduce specific genetic backgrounds, disease mechanisms, therapeutic targets, or production characteristics, creating sustained demand for gene editing, stable cell-line construction, functional validation, and cell-bank services. Advances in genome editing, cell culture, single-cell analysis, automation, and high-throughput screening are improving technical feasibility and reducing the time required for complex cell-engineering projects. At the same time, pharmaceutical and biotechnology companies increasingly rely on external specialized capabilities to accelerate development schedules and access technical expertise without building every platform internally.

Restraints

Cell Engineering Service is constrained by biological variability, cell-type-specific technical difficulty, project reproducibility, long development cycles for complex models, and requirements for specialized personnel and laboratory infrastructure. Some primary cells, stem cells, immune cells, and difficult-to-transfect cell types require customized culture conditions and engineering strategies, which can increase project complexity. Multi-step workflows involving editing, clone isolation, validation, and long-term stability testing also create execution risk. For projects moving toward translational or manufacturing applications, documentation, traceability, biosafety, quality-management requirements, and compatibility with downstream processes can further increase service costs and operational burden.

Opportunities

Future opportunities are emerging in complex gene-edited cell models, disease-specific cellular systems, induced pluripotent stem cell engineering, immune-cell modification, high-throughput cell engineering, automated clone screening, synthetic biology, and next-generation bioproduction cell lines. Drug developers increasingly require more physiologically relevant models for target validation, mechanism studies, screening, and translational research, creating opportunities for engineered cells with multiple genetic modifications or specialized functional characteristics. Integration of automation, imaging, single-cell technologies, and computational analysis can further improve project throughput and reproducibility. Service providers that can connect early cell engineering with functional assays, process development, cell banking, and downstream manufacturing support may also capture a broader share of the development value chain.

Challenges

The industry faces continuing challenges in ensuring editing accuracy, clone stability, functional reproducibility, scalable workflows, and reliable quality control across different cell types. More complex engineering projects can increase the risk of unintended biological effects, clonal variation, or inconsistent phenotype. Standardization is difficult because cell systems differ significantly in growth characteristics, transfection efficiency, genetic stability, and intended application. Service providers also need to balance project customization with operational efficiency while maintaining data integrity, biosafety, and intellectual-property protection. As customers demand increasingly complex cell models and shorter development cycles, the ability to maintain technical quality while improving throughput will remain an important competitive challenge.

Value Chain Analysis

The upstream value chain of Cell Engineering Service includes cell sources, culture media, serum and supplements, gene-editing reagents, vectors, nucleic acids, enzymes, antibodies, selection reagents, analytical consumables, cell-culture equipment, imaging systems, flow cytometry, sequencing technologies, automation equipment, and laboratory data infrastructure. These inputs provide the biological materials, engineering tools, analytical capabilities, and process infrastructure required for cell modification and validation. Reagent quality, cell-source consistency, instrument performance, biosafety controls, and data traceability directly affect project success and reproducibility.

The midstream value chain covers project design, cell culture, transfection or gene editing, clone isolation, clone screening, molecular characterization, functional testing, stability assessment, cell-bank establishment, process optimization, scale-up, and technical documentation. Value creation mainly comes from technical expertise, successful engineering efficiency, reproducibility, shortened development timelines, and the ability to connect cell construction with downstream research or production requirements. Downstream users include biopharmaceutical companies, drug discovery organizations, cell and gene therapy developers, regenerative medicine organizations, diagnostic developers, contract research and development organizations, academic institutions, and other biotechnology users.

Downstream Market Opportunities

Cell Engineering Service has broad downstream opportunities across biopharmaceutical development, drug discovery, cell and gene therapy, regenerative medicine, diagnostics, contract research, and academic research. Biopharmaceutical developers require stable production cell lines, high-expression clones, and engineered disease models; drug discovery programs use modified cell systems for target validation, screening, mechanism studies, and efficacy assessment; cell and gene therapy developers require more sophisticated modification and characterization of immune cells, stem cells, and other therapeutic cell types. Regenerative medicine and precision research are increasing demand for patient-relevant and stem-cell-derived models, while diagnostic and research applications continue to require standardized engineered cells. The expansion of advanced biological research is therefore broadening both the technical depth and application scope of Cell Engineering Service.

Regional Insights

North America has a mature biotechnology and pharmaceutical research ecosystem, with extensive activity in biologics, cell and gene therapy, drug discovery, and advanced cell-model development, supporting demand for complex and highly customized Cell Engineering Service. Europe also has strong capabilities in biopharmaceutical research, regenerative medicine, biotechnology, and translational science, with customers placing significant emphasis on technical quality, documentation, reproducibility, and regulatory readiness. Asia-Pacific is expanding rapidly in biopharmaceutical research, contract development, innovative drug development, and cell-based technologies, creating increasing demand for both cost-efficient and technically advanced cell-engineering services. China is strengthening its capabilities in biologics, innovative therapeutics, gene editing, and outsourced research, while Japan maintains strong demand in regenerative medicine, stem-cell research, pharmaceutical development, and high-quality specialized cell technologies. Regional competition is increasingly influenced by technical specialization, project delivery capability, quality systems, and integration with downstream development services.

Report Scope

LPI (LP Information)' newest research report, the “Cell Engineering Service Industry Forecast” looks at past sales and reviews total world Cell Engineering Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Engineering Service sales for 2026 through 2032. With Cell Engineering Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Engineering Service industry.

This Insight Report provides a comprehensive analysis of the global Cell Engineering Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Engineering Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Engineering Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Engineering Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Engineering Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Engineering Service market by product type, application, key players and key regions and countries.

Market Segmentation

Segmentation by Type:

• Gene Editing
• Cell Line Development
• Others

Segmentation by Cell Type:

• Mammalian Cell Engineering Service
• Microbial Cell Engineering Service
• Plant and Insect Cell Engineering Service

Segmentation by Service Model:

• Process Development and Production Service
• Platform and Automation Service

Segmentation by Number of Cell Types Covered:

• Specialized Type (?3 Cell Types)
• Multi-Type (4-10 Cell Types)
• Comprehensive Platform Type (>10 Cell Types)

Segmentation by Application:

• Medical Industry
• Scientific Research
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermo Fisher Scientific
• Revvity
• Charles River Laboratories
• System Biosciences
• REPROCELL
• Lonza
• Sartorius
• Merck
• Evotec
• InSCREENeX
• WuXi Biologics
• GenScript
• OBiO Technology
• Tsingke Biotechnology
• Takara Bio
• Setsuro Tech
• Funakoshi
• Kamakura Techno-Science
• Unitec

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cell Engineering Service Market Size (2021-2032)
  2.1.2 Cell Engineering Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Cell Engineering Service by Country/Region (2021, 2025 & 2032)
2.2 Cell Engineering Service Segment by Type
  2.2.1 Gene Editing
  2.2.2 Cell Line Development
  2.2.3 Others
  2.2.4 Cell Engineering Service Market Size by Type
    2.2.4.1 Cell Engineering Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Cell Engineering Service Market Size Market Share by Type (2021-2026)
2.3 Cell Engineering Service Segment by Cell Type
  2.3.1 Mammalian Cell Engineering Service
  2.3.2 Microbial Cell Engineering Service
  2.3.3 Plant and Insect Cell Engineering Service
  2.3.4 Cell Engineering Service Market Size by Cell Type
    2.3.4.1 Cell Engineering Service Market Size CAGR by Cell Type (2021 VS 2025 VS 2032)
    2.3.4.2 Global Cell Engineering Service Market Size Market Share by Cell Type (2021-2026)
2.4 Cell Engineering Service Segment by Service Model
  2.4.1 Process Development and Production Service
  2.4.2 Platform and Automation Service
  2.4.3 Cell Engineering Service Market Size by Service Model
    2.4.3.1 Cell Engineering Service Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
    2.4.3.2 Global Cell Engineering Service Market Size Market Share by Service Model (2021-2026)
2.5 Cell Engineering Service Segment by Number of Cell Types Covered
  2.5.1 Specialized Type (?3 Cell Types)
  2.5.2 Multi-Type (4-10 Cell Types)
  2.5.3 Comprehensive Platform Type (>10 Cell Types)
  2.5.4 Cell Engineering Service Market Size by Number of Cell Types Covered
    2.5.4.1 Cell Engineering Service Market Size CAGR by Number of Cell Types Covered (2021 VS 2025 VS 2032)
    2.5.4.2 Global Cell Engineering Service Market Size Market Share by Number of Cell Types Covered (2021-2026)
2.6 Cell Engineering Service Segment by Application
  2.6.1 Medical Industry
  2.6.2 Scientific Research
  2.6.3 Others
  2.6.4 Cell Engineering Service Market Size by Application
    2.6.4.1 Cell Engineering Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.6.4.2 Global Cell Engineering Service Market Size Market Share by Application (2021-2026)

3 CELL ENGINEERING SERVICE MARKET SIZE BY PLAYER

3.1 Cell Engineering Service Market Size Market Share by Player
  3.1.1 Global Cell Engineering Service Revenue by Player (2021-2026)
  3.1.2 Global Cell Engineering Service Revenue Market Share by Player (2021-2026)
3.2 Global Cell Engineering Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CELL ENGINEERING SERVICE BY REGION

4.1 Cell Engineering Service Market Size by Region (2021-2026)
4.2 Global Cell Engineering Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell Engineering Service Market Size Growth (2021-2026)
4.4 APAC Cell Engineering Service Market Size Growth (2021-2026)
4.5 Europe Cell Engineering Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell Engineering Service Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Cell Engineering Service Market Size by Country (2021-2026)
5.2 Americas Cell Engineering Service Market Size by Type (2021-2026)
5.3 Americas Cell Engineering Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cell Engineering Service Market Size by Region (2021-2026)
6.2 APAC Cell Engineering Service Market Size by Type (2021-2026)
6.3 APAC Cell Engineering Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cell Engineering Service Market Size by Country (2021-2026)
7.2 Europe Cell Engineering Service Market Size by Type (2021-2026)
7.3 Europe Cell Engineering Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cell Engineering Service by Region (2021-2026)
8.2 Middle East & Africa Cell Engineering Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell Engineering Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CELL ENGINEERING SERVICE MARKET FORECAST

10.1 Global Cell Engineering Service Forecast by Region (2027-2032)
  10.1.1 Global Cell Engineering Service Forecast by Region (2027-2032)
  10.1.2 Americas Cell Engineering Service Forecast
  10.1.3 APAC Cell Engineering Service Forecast
  10.1.4 Europe Cell Engineering Service Forecast
  10.1.5 Middle East & Africa Cell Engineering Service Forecast
10.2 Americas Cell Engineering Service Forecast by Country (2027-2032)
  10.2.1 United States Market Cell Engineering Service Forecast
  10.2.2 Canada Market Cell Engineering Service Forecast
  10.2.3 Mexico Market Cell Engineering Service Forecast
  10.2.4 Brazil Market Cell Engineering Service Forecast
10.3 APAC Cell Engineering Service Forecast by Region (2027-2032)
  10.3.1 China Cell Engineering Service Market Forecast
  10.3.2 Japan Market Cell Engineering Service Forecast
  10.3.3 Korea Market Cell Engineering Service Forecast
  10.3.4 Southeast Asia Market Cell Engineering Service Forecast
  10.3.5 India Market Cell Engineering Service Forecast
  10.3.6 Australia Market Cell Engineering Service Forecast
10.4 Europe Cell Engineering Service Forecast by Country (2027-2032)
  10.4.1 Germany Market Cell Engineering Service Forecast
  10.4.2 France Market Cell Engineering Service Forecast
  10.4.3 UK Market Cell Engineering Service Forecast
  10.4.4 Italy Market Cell Engineering Service Forecast
  10.4.5 Russia Market Cell Engineering Service Forecast
10.5 Middle East & Africa Cell Engineering Service Forecast by Region (2027-2032)
  10.5.1 Egypt Market Cell Engineering Service Forecast
  10.5.2 South Africa Market Cell Engineering Service Forecast
  10.5.3 Israel Market Cell Engineering Service Forecast
  10.5.4 Turkey Market Cell Engineering Service Forecast
10.6 Global Cell Engineering Service Forecast by Type (2027-2032)
10.7 Global Cell Engineering Service Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Cell Engineering Service Forecast

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Information
  11.1.2 Thermo Fisher Scientific Cell Engineering Service Product Offered
  11.1.3 Thermo Fisher Scientific Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Thermo Fisher Scientific Main Business Overview
  11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Revvity
  11.2.1 Revvity Company Information
  11.2.2 Revvity Cell Engineering Service Product Offered
  11.2.3 Revvity Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Revvity Main Business Overview
  11.2.5 Revvity Latest Developments
11.3 Charles River Laboratories
  11.3.1 Charles River Laboratories Company Information
  11.3.2 Charles River Laboratories Cell Engineering Service Product Offered
  11.3.3 Charles River Laboratories Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Charles River Laboratories Main Business Overview
  11.3.5 Charles River Laboratories Latest Developments
11.4 System Biosciences
  11.4.1 System Biosciences Company Information
  11.4.2 System Biosciences Cell Engineering Service Product Offered
  11.4.3 System Biosciences Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 System Biosciences Main Business Overview
  11.4.5 System Biosciences Latest Developments
11.5 REPROCELL
  11.5.1 REPROCELL Company Information
  11.5.2 REPROCELL Cell Engineering Service Product Offered
  11.5.3 REPROCELL Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 REPROCELL Main Business Overview
  11.5.5 REPROCELL Latest Developments
11.6 Lonza
  11.6.1 Lonza Company Information
  11.6.2 Lonza Cell Engineering Service Product Offered
  11.6.3 Lonza Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Lonza Main Business Overview
  11.6.5 Lonza Latest Developments
11.7 Sartorius
  11.7.1 Sartorius Company Information
  11.7.2 Sartorius Cell Engineering Service Product Offered
  11.7.3 Sartorius Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Sartorius Main Business Overview
  11.7.5 Sartorius Latest Developments
11.8 Merck
  11.8.1 Merck Company Information
  11.8.2 Merck Cell Engineering Service Product Offered
  11.8.3 Merck Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Merck Main Business Overview
  11.8.5 Merck Latest Developments
11.9 Evotec
  11.9.1 Evotec Company Information
  11.9.2 Evotec Cell Engineering Service Product Offered
  11.9.3 Evotec Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Evotec Main Business Overview
  11.9.5 Evotec Latest Developments
11.10 InSCREENeX
  11.10.1 InSCREENeX Company Information
  11.10.2 InSCREENeX Cell Engineering Service Product Offered
  11.10.3 InSCREENeX Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 InSCREENeX Main Business Overview
  11.10.5 InSCREENeX Latest Developments
11.11 WuXi Biologics
  11.11.1 WuXi Biologics Company Information
  11.11.2 WuXi Biologics Cell Engineering Service Product Offered
  11.11.3 WuXi Biologics Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 WuXi Biologics Main Business Overview
  11.11.5 WuXi Biologics Latest Developments
11.12 GenScript
  11.12.1 GenScript Company Information
  11.12.2 GenScript Cell Engineering Service Product Offered
  11.12.3 GenScript Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 GenScript Main Business Overview
  11.12.5 GenScript Latest Developments
11.13 OBiO Technology
  11.13.1 OBiO Technology Company Information
  11.13.2 OBiO Technology Cell Engineering Service Product Offered
  11.13.3 OBiO Technology Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 OBiO Technology Main Business Overview
  11.13.5 OBiO Technology Latest Developments
11.14 Tsingke Biotechnology
  11.14.1 Tsingke Biotechnology Company Information
  11.14.2 Tsingke Biotechnology Cell Engineering Service Product Offered
  11.14.3 Tsingke Biotechnology Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Tsingke Biotechnology Main Business Overview
  11.14.5 Tsingke Biotechnology Latest Developments
11.15 Takara Bio
  11.15.1 Takara Bio Company Information
  11.15.2 Takara Bio Cell Engineering Service Product Offered
  11.15.3 Takara Bio Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Takara Bio Main Business Overview
  11.15.5 Takara Bio Latest Developments
11.16 Setsuro Tech
  11.16.1 Setsuro Tech Company Information
  11.16.2 Setsuro Tech Cell Engineering Service Product Offered
  11.16.3 Setsuro Tech Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 Setsuro Tech Main Business Overview
  11.16.5 Setsuro Tech Latest Developments
11.17 Funakoshi
  11.17.1 Funakoshi Company Information
  11.17.2 Funakoshi Cell Engineering Service Product Offered
  11.17.3 Funakoshi Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Funakoshi Main Business Overview
  11.17.5 Funakoshi Latest Developments
11.18 Kamakura Techno-Science
  11.18.1 Kamakura Techno-Science Company Information
  11.18.2 Kamakura Techno-Science Cell Engineering Service Product Offered
  11.18.3 Kamakura Techno-Science Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Kamakura Techno-Science Main Business Overview
  11.18.5 Kamakura Techno-Science Latest Developments
11.19 Unitec
  11.19.1 Unitec Company Information
  11.19.2 Unitec Cell Engineering Service Product Offered
  11.19.3 Unitec Cell Engineering Service Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 Unitec Main Business Overview
  11.19.5 Unitec Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cell Engineering Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell Engineering Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Gene Editing
Table 4. Major Players of Cell Line Development
Table 5. Major Players of Others
Table 6. Cell Engineering Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cell Engineering Service Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cell Engineering Service Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Mammalian Cell Engineering Service
Table 10. Major Players of Microbial Cell Engineering Service
Table 11. Major Players of Plant and Insect Cell Engineering Service
Table 12. Cell Engineering Service Market Size CAGR by Cell Type (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Cell Engineering Service Market Size by Cell Type (2021-2026) & ($ millions)
Table 14. Global Cell Engineering Service Market Size Market Share by Cell Type (2021-2026)
Table 15. Major Players of Process Development and Production Service
Table 16. Major Players of Platform and Automation Service
Table 17. Cell Engineering Service Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Cell Engineering Service Market Size by Service Model (2021-2026) & ($ millions)
Table 19. Global Cell Engineering Service Market Size Market Share by Service Model (2021-2026)
Table 20. Major Players of Specialized Type (?3 Cell Types)
Table 21. Major Players of Multi-Type (4-10 Cell Types)
Table 22. Major Players of Comprehensive Platform Type (>10 Cell Types)
Table 23. Cell Engineering Service Market Size CAGR by Number of Cell Types Covered (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Cell Engineering Service Market Size by Number of Cell Types Covered (2021-2026) & ($ millions)
Table 25. Global Cell Engineering Service Market Size Market Share by Number of Cell Types Covered (2021-2026)
Table 26. Cell Engineering Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Cell Engineering Service Market Size by Application (2021-2026) & ($ millions)
Table 28. Global Cell Engineering Service Market Size Market Share by Application (2021-2026)
Table 29. Global Cell Engineering Service Revenue by Player (2021-2026) & ($ millions)
Table 30. Global Cell Engineering Service Revenue Market Share by Player (2021-2026)
Table 31. Cell Engineering Service Key Players Head office and Products Offered
Table 32. Cell Engineering Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Mergers & Acquisitions, Expansion
Table 35. Global Cell Engineering Service Market Size by Region (2021-2026) & ($ millions)
Table 36. Global Cell Engineering Service Market Size Market Share by Region (2021-2026)
Table 37. Global Cell Engineering Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 38. Global Cell Engineering Service Revenue Market Share by Country/Region (2021-2026)
Table 39. Americas Cell Engineering Service Market Size by Country (2021-2026) & ($ millions)
Table 40. Americas Cell Engineering Service Market Size Market Share by Country (2021-2026)
Table 41. Americas Cell Engineering Service Market Size by Type (2021-2026) & ($ millions)
Table 42. Americas Cell Engineering Service Market Size Market Share by Type (2021-2026)
Table 43. Americas Cell Engineering Service Market Size by Application (2021-2026) & ($ millions)
Table 44. Americas Cell Engineering Service Market Size Market Share by Application (2021-2026)
Table 45. APAC Cell Engineering Service Market Size by Region (2021-2026) & ($ millions)
Table 46. APAC Cell Engineering Service Market Size Market Share by Region (2021-2026)
Table 47. APAC Cell Engineering Service Market Size by Type (2021-2026) & ($ millions)
Table 48. APAC Cell Engineering Service Market Size by Application (2021-2026) & ($ millions)
Table 49. Europe Cell Engineering Service Market Size by Country (2021-2026) & ($ millions)
Table 50. Europe Cell Engineering Service Market Size Market Share by Country (2021-2026)
Table 51. Europe Cell Engineering Service Market Size by Type (2021-2026) & ($ millions)
Table 52. Europe Cell Engineering Service Market Size by Application (2021-2026) & ($ millions)
Table 53. Middle East & Africa Cell Engineering Service Market Size by Region (2021-2026) & ($ millions)
Table 54. Middle East & Africa Cell Engineering Service Market Size by Type (2021-2026) & ($ millions)
Table 55. Middle East & Africa Cell Engineering Service Market Size by Application (2021-2026) & ($ millions)
Table 56. Key Market Drivers & Growth Opportunities of Cell Engineering Service
Table 57. Key Market Challenges & Risks of Cell Engineering Service
Table 58. Key Industry Trends of Cell Engineering Service
Table 59. Global Cell Engineering Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 60. Global Cell Engineering Service Market Size Market Share Forecast by Region (2027-2032)
Table 61. Global Cell Engineering Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 62. Global Cell Engineering Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 63. Thermo Fisher Scientific Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 64. Thermo Fisher Scientific Cell Engineering Service Product Offered
Table 65. Thermo Fisher Scientific Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Thermo Fisher Scientific Main Business
Table 67. Thermo Fisher Scientific Latest Developments
Table 68. Revvity Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 69. Revvity Cell Engineering Service Product Offered
Table 70. Revvity Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Revvity Main Business
Table 72. Revvity Latest Developments
Table 73. Charles River Laboratories Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 74. Charles River Laboratories Cell Engineering Service Product Offered
Table 75. Charles River Laboratories Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Charles River Laboratories Main Business
Table 77. Charles River Laboratories Latest Developments
Table 78. System Biosciences Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 79. System Biosciences Cell Engineering Service Product Offered
Table 80. System Biosciences Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. System Biosciences Main Business
Table 82. System Biosciences Latest Developments
Table 83. REPROCELL Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 84. REPROCELL Cell Engineering Service Product Offered
Table 85. REPROCELL Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. REPROCELL Main Business
Table 87. REPROCELL Latest Developments
Table 88. Lonza Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 89. Lonza Cell Engineering Service Product Offered
Table 90. Lonza Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Lonza Main Business
Table 92. Lonza Latest Developments
Table 93. Sartorius Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 94. Sartorius Cell Engineering Service Product Offered
Table 95. Sartorius Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Sartorius Main Business
Table 97. Sartorius Latest Developments
Table 98. Merck Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 99. Merck Cell Engineering Service Product Offered
Table 100. Merck Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Evotec Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 104. Evotec Cell Engineering Service Product Offered
Table 105. Evotec Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Evotec Main Business
Table 107. Evotec Latest Developments
Table 108. InSCREENeX Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 109. InSCREENeX Cell Engineering Service Product Offered
Table 110. InSCREENeX Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. InSCREENeX Main Business
Table 112. InSCREENeX Latest Developments
Table 113. WuXi Biologics Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 114. WuXi Biologics Cell Engineering Service Product Offered
Table 115. WuXi Biologics Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. WuXi Biologics Main Business
Table 117. WuXi Biologics Latest Developments
Table 118. GenScript Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 119. GenScript Cell Engineering Service Product Offered
Table 120. GenScript Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. GenScript Main Business
Table 122. GenScript Latest Developments
Table 123. OBiO Technology Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 124. OBiO Technology Cell Engineering Service Product Offered
Table 125. OBiO Technology Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. OBiO Technology Main Business
Table 127. OBiO Technology Latest Developments
Table 128. Tsingke Biotechnology Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 129. Tsingke Biotechnology Cell Engineering Service Product Offered
Table 130. Tsingke Biotechnology Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Tsingke Biotechnology Main Business
Table 132. Tsingke Biotechnology Latest Developments
Table 133. Takara Bio Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 134. Takara Bio Cell Engineering Service Product Offered
Table 135. Takara Bio Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Takara Bio Main Business
Table 137. Takara Bio Latest Developments
Table 138. Setsuro Tech Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 139. Setsuro Tech Cell Engineering Service Product Offered
Table 140. Setsuro Tech Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Setsuro Tech Main Business
Table 142. Setsuro Tech Latest Developments
Table 143. Funakoshi Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 144. Funakoshi Cell Engineering Service Product Offered
Table 145. Funakoshi Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Funakoshi Main Business
Table 147. Funakoshi Latest Developments
Table 148. Kamakura Techno-Science Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 149. Kamakura Techno-Science Cell Engineering Service Product Offered
Table 150. Kamakura Techno-Science Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Kamakura Techno-Science Main Business
Table 152. Kamakura Techno-Science Latest Developments
Table 153. Unitec Details, Company Type, Cell Engineering Service Area Served and Its Competitors
Table 154. Unitec Cell Engineering Service Product Offered
Table 155. Unitec Cell Engineering Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Unitec Main Business
Table 157. Unitec Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cell Engineering Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Engineering Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell Engineering Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell Engineering Service Sales Market Share by Country/Region (2025)
Figure 8. Cell Engineering Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell Engineering Service Market Size Market Share by Type in 2025
Figure 10. Global Cell Engineering Service Market Size Market Share by Cell Type in 2025
Figure 11. Global Cell Engineering Service Market Size Market Share by Service Model in 2025
Figure 12. Global Cell Engineering Service Market Size Market Share by Number of Cell Types Covered in 2025
Figure 13. Cell Engineering Service in Medical Industry
Figure 14. Global Cell Engineering Service Market: Medical Industry (2021-2026) & ($ millions)
Figure 15. Cell Engineering Service in Scientific Research
Figure 16. Global Cell Engineering Service Market: Scientific Research (2021-2026) & ($ millions)
Figure 17. Cell Engineering Service in Others
Figure 18. Global Cell Engineering Service Market: Others (2021-2026) & ($ millions)
Figure 19. Global Cell Engineering Service Market Size Market Share by Application in 2025
Figure 20. Global Cell Engineering Service Revenue Market Share by Player in 2025
Figure 21. Global Cell Engineering Service Market Size Market Share by Region (2021-2026)
Figure 22. Americas Cell Engineering Service Market Size 2021-2026 ($ millions)
Figure 23. APAC Cell Engineering Service Market Size 2021-2026 ($ millions)
Figure 24. Europe Cell Engineering Service Market Size 2021-2026 ($ millions)
Figure 25. Middle East & Africa Cell Engineering Service Market Size 2021-2026 ($ millions)
Figure 26. Americas Cell Engineering Service Value Market Share by Country in 2025
Figure 27. United States Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 28. Canada Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Mexico Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Brazil Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 31. APAC Cell Engineering Service Market Size Market Share by Region in 2025
Figure 32. APAC Cell Engineering Service Market Size Market Share by Type (2021-2026)
Figure 33. APAC Cell Engineering Service Market Size Market Share by Application (2021-2026)
Figure 34. China Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 35. Japan Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 36. South Korea Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 37. Southeast Asia Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 38. India Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 39. Australia Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 40. Europe Cell Engineering Service Market Size Market Share by Country in 2025
Figure 41. Europe Cell Engineering Service Market Size Market Share by Type (2021-2026)
Figure 42. Europe Cell Engineering Service Market Size Market Share by Application (2021-2026)
Figure 43. Germany Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 44. France Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 45. UK Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 46. Italy Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Russia Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Middle East & Africa Cell Engineering Service Market Size Market Share by Region (2021-2026)
Figure 49. Middle East & Africa Cell Engineering Service Market Size Market Share by Type (2021-2026)
Figure 50. Middle East & Africa Cell Engineering Service Market Size Market Share by Application (2021-2026)
Figure 51. Egypt Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 52. South Africa Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Israel Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 54. Turkey Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 55. GCC Countries Cell Engineering Service Market Size Growth 2021-2026 ($ millions)
Figure 56. Americas Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 57. APAC Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 58. Europe Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 59. Middle East & Africa Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 60. United States Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 61. Canada Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 62. Mexico Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 63. Brazil Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 64. China Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 65. Japan Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 66. Korea Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 67. Southeast Asia Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 68. India Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 69. Australia Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 70. Germany Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 71. France Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 72. UK Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 73. Italy Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 74. Russia Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 75. Egypt Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 76. South Africa Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 77. Israel Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 78. Turkey Cell Engineering Service Market Size 2027-2032 ($ millions)
Figure 79. Global Cell Engineering Service Market Size Market Share Forecast by Type (2027-2032)
Figure 80. Global Cell Engineering Service Market Size Market Share Forecast by Application (2027-2032)
Figure 81. GCC Countries Cell Engineering Service Market Size 2027-2032 ($ millions)